Governments worldwide are using digital contact tracing (DCT) apps as a critical element in their COVID-19 pandemic lockdown exit strategy. Despite substantial investment in research and development, the public's acceptance of DCT apps has been phenomenally low, signaling resistance among potential users. Little is known about why people would resist using the DCT app, a useful innovation that can potentially save millions of human lives. This study explores the determinants and consequences of citizens' resistance to use DCT apps using a sequential two-stage mixed-methods approach. The preliminary qualitative study analyzed interviews of 24 Indian smartphone users who chose not to use or discontinued the DCT app after an initial trial. In the quantitative stage, an integrated model based on innovation resistance theory and distrust theory was tested using the survey data collected from 194 non-adopters of the DCT app from India. The findings revealed that the factors, distrust, value barrier, information privacy concerns, and usage barrier predicted the resistance to the DCT app, and resistance, in turn, predicted intention to use. Additionally, distrust was found to be a key mediator between innovation barriers and resistance. The insights from this study could help the developers and policymakers formulate strategies for implementing DCT interventions during future disease outbreaks.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9755900 | PMC |
http://dx.doi.org/10.1016/j.ijinfomgt.2021.102468 | DOI Listing |
JMIR Hum Factors
June 2024
Institute for Multimedia and Interactive Systems, Universität zu Lübeck, Lübeck, Germany.
Background: In pandemic situations, digital contact tracing (DCT) can be an effective way to assess one's risk of infection and inform others in case of infection. DCT apps can support the information gathering and analysis processes of users aiming to trace contacts. However, users' use intention and use of DCT information may depend on the perceived benefits of contact tracing.
View Article and Find Full Text PDFHealth Policy
June 2024
Department of Public Health, University of Otago, Wellington, New Zealand.
Background: Digital contact tracing (DCT) aims to improve time-to-isolation (timeliness) and find more potentially exposed individuals (sensitivity) to enhance the utility of contact tracing. The aim of this study was to evaluate the public uptake of a DCT self-service survey and its integration with the Bluetooth exposure notification system within the New Zealand Covid Tracer App (NZCTA).
Methods: We adopted a retrospective cohort study design using community COVID-19 cases from February 2022 to August 2022 in New Zealand (1.
Epidemiol Infect
April 2024
Department of Public Health, University of Otago, Wellington, New Zealand.
Transl Clin Pharmacol
March 2024
Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Korea.
Decentralized clinical trials (DCTs) consist of off-site trial-related procedures referred to as decentralized elements. We aimed to provide an overview of the landscape of DCTs by comparing regulatory guidance reports and analyzing decentralized elements from clinical trial registries. Two guidance reports on DCTs published by the U.
View Article and Find Full Text PDFHealth Expect
April 2024
Department of Public Health, University of Otago, Wellington, New Zealand.
Background: Digital contact tracing (DCT) was a central component of the global response to containing COVID-19. Research has raised concerns that DCT could exacerbate inequities, yet the experiences of diverse communities at greater risk from COVID-19 are typically underrepresented.
Methods: The present study aimed to understand the perceived barriers to the adoption of the app amongst Māori, Pasifika, and disabled people.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!